Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_assertion type Assertion NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_head.
- NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_assertion description "[The HRD-LOH assay was able to identify patients with sporadic triple-negative breast cancer lacking a BRCA1/2 mutation, but with an elevated HRD-LOH score, who achieved a favorable pathologic response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_provenance.
- NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_assertion evidence source_evidence_literature NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_provenance.
- NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_assertion SIO_000772 25847929 NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_provenance.
- NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_assertion wasDerivedFrom befree-2016 NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_provenance.
- NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_assertion wasGeneratedBy ECO_0000203 NP1276267.RAfTfjkalVsV0hLDLEVrQYepTpi0r32O1EDEEheEiL9pA130_provenance.